Thu, Sep 18, 2014, 9:24 AM EDT - U.S. Markets open in 6 mins.


% | $
Quotes you view appear here for quick access.

Neostem, Inc. Message Board

  • welllookyhere2013 welllookyhere2013 Sep 16, 2013 12:09 PM Flag

    NBS Victim of Orchestrated Short Selling

    This stock was set up for a fall by a flood of negative posts over the weekend, followed by two SA pieces pumping a potential competitor. Another example of the importance of reading up on the science behind a biotech before you decide to invest or bail out.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • It was definitely orchestrated. We were hit by a team of short sellers/publishers, who strategically instilled doubt after a nice run up. To be honest, they found a great target, and by the close today, they will have covered 1/3 - 1/2 their position to lock in 10%+ gains. The execution was well planned, and I take my hat off to the team. Picking a single weak point about the AMR-001 published study and implying a blanket failure without actually mentioning all the positive improvments to heart function. Then suggesting another company has the complete solution. Having the crazy crowd post follow-up lies is making it look even more insane today.

      Sentiment: Strong Buy

    • Big pharma is getting people's shares cheap. That is all I can say. People are not wise to sell right now for no reason. That study using a different cell population than Amorcyte was actually very very good news if you understand the science of myocardial infarctions or just science in general

5.13Sep 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Rite Aid Corporation
NYSEWed, Sep 17, 2014 4:00 PM EDT
Auxilium Pharmaceuticals Inc.
NasdaqGSWed, Sep 17, 2014 3:59 PM EDT